# COVID-19 Clinical Trials Data Analysis

## üìò Overview
This project performs an **exploratory data analysis (EDA)** of global COVID-19 clinical trials to uncover meaningful trends, patterns, and insights from public datasets.  
The analysis focuses on understanding how different types of studies were conducted worldwide ‚Äî including vaccine and treatment trials ‚Äî and how they evolved across study phases, regions, and intervention categories.

The goal is to provide **data-driven insights** into clinical research efforts during the COVID-19 pandemic.

---

## üß© Objectives
- Analyze the **geographical distribution** of COVID-19 clinical trials.
- Study the **trial phases** and **completion status**.
- Identify common **intervention types** and **study sponsors**.
- Visualize temporal trends in clinical trial registrations.
- Derive insights that reflect the global research response to COVID-19.

---

Each record generally includes:
- Trial ID / NCT Number  
- Study Title  
- Phase (I, II, III, IV)  
- Study Type (Interventional / Observational)  
- Location / Country  
- Start and Completion Dates  
- Intervention Name  
- Sponsor / Organization  
- Recruitment Status  

---

## ‚öôÔ∏è Methodology
1. **Data Loading & Cleaning**
   - Handled missing values and inconsistent entries.
   - Standardized column names and formats.
   - Filtered out non-COVID-related or incomplete studies.

2. **Exploratory Data Analysis**
   - Distribution of trials by **country**, **phase**, and **status**.
   - Analysis of **study design** and **intervention types**.
   - Visualization of **temporal trends** (number of trials registered per month).
   - Comparison between **vaccine vs. non-vaccine** studies.

3. **Visualization**
   - Used `Matplotlib` and `Seaborn` for creating bar charts, histograms, and heatmaps.
   - Plotted world maps showing geographical spread (optional if geopandas/plotly used).

4. **Insights & Findings**
   - Countries with the most clinical trials.
   - Most common intervention types.
   - Trends in study phases and completion rates over time.

---

## üß∞ Tools & Technologies
- **Language:** Python 3.x  
- **Libraries:** Pandas, NumPy, Matplotlib, Seaborn, Plotly (optional)  
- **Environment:** Jupyter Notebook / Visual Studio Code  

---

## üìä Results & Key Insights
- The majority of clinical trials were conducted in the **United States, India, and China**.  
- A significant proportion of studies were **interventional**, focusing on drug and vaccine testing.  
- **Phase II and III** trials were the most frequent, reflecting mid-stage and late-stage research focus.  
- Global collaboration increased significantly between 2020‚Äì2022, highlighting the unified scientific response to the pandemic.

---
